Lysophosphatidic Acid Increases Maturation of Brush Borders and SGLT1 Activity in MYO5B-deficient Mice, a Model of Microvillus Inclusion Disease is a research paper published in Gastroenterology (2020). On theSindex it has a DataRank of 0. It has been cited 55 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Vanderbilt-Ingram Cancer Center
Grant: P30 CA68485
Vanderbilt-Ingram Cancer Center
Grant: 1IS1BX003097
National Institutes of Health
Grant: F32 DK111101
National Institutes of Health
Grant: R01 DK48370
National Institutes of Health
Grant: R01 DK70856
National Institutes of Health
Grant: RC2 DK118640
Cystic Fibrosis Foundation
Grant: HODGES19R1
NIDDK NIH HHS
Grant: P30 DK123704
NIDDK NIH HHS
Grant: P30 DK058404
NIDDK NIH HHS
Grant: R01 DK048370
NIDDK NIH HHS
Grant: R01 DK070856
BLRD VA
Grant: IS1 BX003097
NCI NIH HHS
Grant: P30 CA068485
NIDDK NIH HHS
Grant: K01 DK121869
MeSH Terms
Keywords
Additional file 1 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
Additional file 1 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
Additional file 4 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
Additional file 4 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
Additional file 5 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
Additional file 5 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
Additional file 2 of MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report
Additional file 2 of MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report
Additional file 4 of MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report
Additional file 4 of MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report
Additional file 3 of MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report
Additional file 3 of MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report
Additional file 1 of MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report
Additional file 1 of MYO5B gene mutations may promote the occurrence of very early onset inflammatory bowel disease: a case report
Additional file 2 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
Additional file 2 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
Additional file 3 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
Additional file 3 of Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6